These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 24283361)

  • 1. Association between seven common OPG genetic polymorphisms and osteoporosis risk: a meta-analysis.
    Guo L; Tang K; Quan Z; Zhao Z; Jiang D
    DNA Cell Biol; 2014 Jan; 33(1):29-39. PubMed ID: 24283361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significant associations between the A163G and G1181C polymorphisms of the osteoprotegerin gene and risk of osteoporosis, especially in postmenopausal women: a meta-analysis.
    Luo Y; Hu Z; Hao J; Jiang W; Shen J; Zhao J
    Genet Test Mol Biomarkers; 2014 Mar; 18(3):211-9. PubMed ID: 24410296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between
    Han X; Zheng L; Mu YY; Li HZ; He XF
    Front Genet; 2022; 13():1032110. PubMed ID: 36437941
    [No Abstract]   [Full Text] [Related]  

  • 4. The genetic association between osteoprotegerin (OPG) gene polymorphisms and bone mineral density (BMD) in postmenopausal women: A meta-analysis.
    Peng Y; Sheng X; Xue F; Qian Y
    Medicine (Baltimore); 2018 Dec; 97(51):e13507. PubMed ID: 30572450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common Variants of the
    Li X; Cheng J; Dong B; Yu X; Zhao X; Zhou Z
    Genet Test Mol Biomarkers; 2021 Sep; 25(9):600-610. PubMed ID: 34515523
    [No Abstract]   [Full Text] [Related]  

  • 6. The association of OPG polymorphisms with risk of osteoporotic fractures: A systematic review and meta-analysis.
    Ding J; Zhang C; Guo Y
    Medicine (Baltimore); 2021 Aug; 100(31):e26716. PubMed ID: 34397809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between osteoprotegerin (OPG), receptor activator of nuclear factor-kappaB (RANK), and RANK ligand (RANKL) gene polymorphisms and circulating OPG, soluble RANKL levels, and bone mineral density in Korean postmenopausal women.
    Kim JG; Kim JH; Kim JY; Ku SY; Jee BC; Suh CS; Kim SH; Choi YM
    Menopause; 2007; 14(5):913-8. PubMed ID: 17667143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between osteoprotegerin gene T950C polymorphism and osteoporosis risk in the Chinese population: Evidence via meta-analysis.
    Li S; Jiang H; Du N
    PLoS One; 2017; 12(12):e0189825. PubMed ID: 29253005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is A163G polymorphism in the osteoprotegerin gene associated with heel velocity of sound in postmenopausal women?
    Zajíčková K; Zemanová A; Hill M; Žofková I
    Physiol Res; 2008; 57 Suppl 1():S153-S157. PubMed ID: 18271681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteoporosis and polymorphisms of osteoprotegerin gene in postmenopausal women - a pilot study.
    Cvijetic S; Grazio S; Kosovic P; Uremovic M; Nemcic T; Bobic J
    Reumatologia; 2016; 54(1):10-3. PubMed ID: 27407270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of osteoporosis risk and polymorphisms of osteoprotegerin gene T950C in postmenopausal Chinese women: A PRISMA-compliant meta-analysis.
    Xia Y; Chen H
    Medicine (Baltimore); 2023 Apr; 102(14):e33511. PubMed ID: 37026909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoprotegerin SNP associations with coronary artery disease and ischemic stroke risk: a meta-analysis.
    Wu J; Li X; Gao F; Gao S; Lyu J; Qiang H
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 32955093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations between osteoprotegerin polymorphisms and bone mineral density: a meta-analysis.
    Lee YH; Woo JH; Choi SJ; Ji JD; Song GG
    Mol Biol Rep; 2010 Jan; 37(1):227-34. PubMed ID: 19642016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Osteoprotegerin gene polymorphism and therapeutic response to alendronate in postmenopausal women with osteoporosis].
    Wang C; He JW; Qin YJ; Zhang H; Hu WW; Liu YJ; Zhang ZL
    Zhonghua Yi Xue Za Zhi; 2009 Nov; 89(42):2958-62. PubMed ID: 20137703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between Osteoprotegerin Gene Polymorphisms and Risk of Coronary Artery Disease: A Systematic Review and Meta-analysis.
    Jia P; Wu N; Jia D; Sun Y
    Balkan J Med Genet; 2017 Dec; 20(2):27-34. PubMed ID: 29876230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteoprotegerin genetic polymorphisms and their influence on therapeutic response to ibandronate in postmenopausal osteoporotic females.
    Tariq S; Tariq S; Abualhamael SA; Baig M; Malik AA; Shahzad M
    PLoS One; 2023; 18(9):e0291959. PubMed ID: 37751449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Association between Val80 polymorphism of the CYP19 gene, A163G polymorphism of the OPG gene and bone mineral density in post-menopausal Chinese women].
    Geng L; Yao ZW; Luo JY; Han LL; Lu Q
    Yi Chuan; 2007 Nov; 29(11):1345-50. PubMed ID: 17989043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphism in vitamin D receptor and osteoprotegerin genes in Egyptian rheumatoid arthritis patients with and without osteoporosis.
    Hussien YM; Shehata A; Karam RA; Alzahrani SS; Magdy H; El-Shafey AM
    Mol Biol Rep; 2013 May; 40(5):3675-80. PubMed ID: 23271131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationships of OPG Genetic Polymorphisms with Susceptibility to Cardiovascular Disease: A Meta-Analysis.
    Song DH; Zhou PZ; Xiu XL; Zhou GH; Sun YX; Song C
    Med Sci Monit; 2016 Apr; 22():1223-31. PubMed ID: 27068490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TNFRSF11B gene polymorphisms, bone mineral density, and fractures in Slovak postmenopausal women.
    Boroňová I; Bernasovská J; Mačeková S; Petrejčíková E; Tomková Z; Kľoc J; Poráčová J; Blaščáková MM; Litavcová E
    J Appl Genet; 2015 Feb; 56(1):57-63. PubMed ID: 25323794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.